DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
PF-03882845 is an investigational drug.
There have been 5 clinical trials for PF-03882845. The most recent clinical trial was a Phase 1 trial, which was initiated on March 1st 2011.
The most common disease conditions in clinical trials are Diabetes Mellitus, Type 2, Kidney Diseases, and Diabetic Nephropathies. The leading clinical trial sponsors are Pfizer and [disabled in preview].
Recent Clinical Trials for PF-03882845
|A Study To Evaluate The Safety And Tolerability Of PF-03882845 In Patients With Type 2 Diabetic Nephropathy||Pfizer||Phase 1|
|Drug-Drug Interaction Study Of Effect Of PF-03882845 On Simvastatin Pharmacokinetics||Pfizer||Phase 1|
|A Single Dose Study Of Antimineralocorticoid Activity Of PF-03882845 In Healthy Volunteers||Pfizer||Phase 1|